Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of Migraine in the Elderly: A Narrated Review
Tissa Wijeratne, Huiliang Melissa Tang, David P. Crewther, et al.
Neuroepidemiology (2019) Vol. 52, Iss. 1-2, pp. 104-110
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 8
Open Access | Times Cited: 27
Serial systemic immune inflammation indices: markers of acute migraine events or indicators of persistent inflammatory status?
Tissa Wijeratne, Melanie Murphy, Chanith Wijeratne, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Management of chronic migraine
Alexandra Hovaguimian, Julie Roth
BMJ (2022), pp. e067670-e067670
Open Access | Times Cited: 55
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Successful treatment of chronic migraine unresponsive to triptans with herbal medicines containing Cinnamomi Cortex: A case report
Han‐Gyul Lee, Seungwon Kwon, Hirozo Goto, et al.
EXPLORE (2025) Vol. 21, Iss. 2, pp. 103115-103115
Closed Access | Times Cited: 1
Classification of Chronic Hydrocephalus in Adults: A Systematic Review and Analysis
Mats Tullberg, Ahmed K. Toma, Shigeki Yamada, et al.
World Neurosurgery (2023) Vol. 183, pp. 113-122
Open Access | Times Cited: 19
Ageing Population: A Neurological Challenge
Yannick Béjot, Kristine Yaffe
Neuroepidemiology (2019) Vol. 52, Iss. 1-2, pp. 76-77
Open Access | Times Cited: 44
Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly’s Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City—Itoigawa Hisui Study
Masahito Katsuki, Junko Kawahara, Yasuhiko Matsumori, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4707-4707
Open Access | Times Cited: 23
Prevalence of migraine in Iran: a systematic review and meta-analysis
Payam Mohammadi, Mahbod Khodamorovati, kamran vafaee, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review
Albert Muñoz‐Vendrell, A. López-Bravo, Almudena Layos-Romero, et al.
Pain Management (2025), pp. 1-11
Closed Access
Migraine with and without aura—two distinct entities? A narrative review
Olga Grodzka, Ketevan Dzagoevi, Tayla A. Rees, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Christian Lampl, Viktoria Kraus, Katrina Lehner, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The evolving concept of multimorbidity and migraine
Claudia Altamura, Gianluca Coppola, Fabrizio Vernieri
Handbook of clinical neurology (2024), pp. 535-566
Closed Access | Times Cited: 3
Prevalence and risk factors of migraine and non-migraine headache in older people – results of the Heinz Nixdorf Recall study
Sara Schramm, Isabell Tenhagen, Börge Schmidt, et al.
Cephalalgia (2020) Vol. 41, Iss. 6, pp. 649-664
Open Access | Times Cited: 25
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Role of endocrine PACAP in age-related diseases
Dénes Tóth, Dóra Reglődi, Lili Schwieters, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Different Aspects of Aging in Migraine
Michał Fila, Elżbieta Pawłowska, Joanna Szczepańska, et al.
Aging and Disease (2023) Vol. 14, Iss. 6, pp. 2028-2028
Open Access | Times Cited: 9
Artificial intelligence analysis to explore synchronize exercise, cobalamin, and magnesium as new actors to therapeutic of migraine symptoms: a randomized, placebo-controlled trial
Hanie Matin, Farzaneh Taghian, Ahmad Chitsaz
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4413-4424
Closed Access | Times Cited: 14
Episodic Migraine and Older Adults
Nina Riggins, Annika Ehrlich
Current Pain and Headache Reports (2022) Vol. 26, Iss. 4, pp. 331-335
Open Access | Times Cited: 14
Physical Activity Level, Depression, Anxiety, and Self-Perceived Health in Spanish Adults with Migraine: A Cross-Sectional Study
Ángel Denche-Zamorano, Víctor Paredes-Mateos, Raquel Pastor-Cisneros, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 21, pp. 13882-13882
Open Access | Times Cited: 13
Currently Available Interventions for the Management of Migraine Pain
Rakesh K. Singh, Shivam Kumar Pandey, Shreya Singh, et al.
(2024), pp. 191-227
Closed Access | Times Cited: 2
Scientific Knowledge Graph of Acupuncture for Migraine: A Bibliometric Analysis from 2000 to 2019
Yanqing Zhao, Li Huang, Meijuan Liu, et al.
Journal of Pain Research (2021) Vol. Volume 14, pp. 1985-2000
Open Access | Times Cited: 15
Eptinezumab for migraine prevention in patients 50 years or older
Vincent T. Martin, Cristina Tassorelli, Anders Ettrup, et al.
Acta Neurologica Scandinavica (2022) Vol. 145, Iss. 6, pp. 698-705
Open Access | Times Cited: 10
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
Virginia L. Stauffer, Ira Turner, Phebe Kemmer, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Tolerability and Safety of Lasmiditan Treatment in Elderly Patients With Migraine: Post Hoc Analyses From Randomized Studies
Vincent T. Martin, Zubair Ahmed, Helen Hochstetler, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 6, pp. 1066-1078
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top